Metraipolis › archive › dc_a04fcc09fdb7

Adverse outcomes in patients hospitalized with pneumonia at age 60 or more: A prospective multi-centric hospital-based study in India — Europe PMC PMID:38696397

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38696397
DOI
10.1371/journal.pone.0297452
License (as archived)
CC0-1.0
Archived
2026-10-06T18:46:45.924Z
SHA-256 of the archived text
f9e5b908a1f0b4150fe34036c762af3b9ac2478d136f5d8a62837e515bee2d57
Stable URL of this page
https://metraipolis.com/documento/dc_a04fcc09fdb7

How to cite

Adverse outcomes in patients hospitalized with pneumonia at age 60 or more: A prospective multi-centric hospital-based study in India — Europe PMC PMID:38696397 — Europe PMC (en), https://europepmc.org/article/MED/38696397 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_a04fcc09fdb7 (Metraipolis archive dc_a04fcc09fdb7, sha256 f9e5b908a1f0b4150fe34036c762af3b9ac2478d136f5d8a62837e515bee2d57)
BibTeX
@misc{dca04fcc09fdb7,
  title = {Adverse outcomes in patients hospitalized with pneumonia at age 60 or more: A prospective multi-centric hospital-based study in India — Europe PMC PMID:38696397},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38696397},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_a04fcc09fdb7; sha256 f9e5b908a1f0b4150fe34036c762af3b9ac2478d136f5d8a62837e515bee2d57},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38696397. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Limited data exists regarding risk factors for adverse outcomes in older adults hospitalized with Community-Acquired Pneumonia (CAP) in low- and middle-income countries such as India. This multisite study aimed to assess outcomes and associated risk factors among adults aged ≥60 years hospitalized with pneumonia. Methods: Between December 2018 and March 2020, we enrolled ≥60-year-old adults admitted within 48 hours for CAP treatment across 16 public and private facilities in four sites. Clinical data and nasal/oropharyngeal specimens were collected by trained nurses and tested for influenza, respiratory syncytial virus (RSV), and other respiratory viruses (ORV) using the qPCR. Participants were evaluated regularly until discharge, as well as on the 7th and 30th days post-discharge. Outcomes included ICU admission and in-hospital or 30-day post-discharge mortality. A hierarchical framework for multivariable logistic regression and Cox proportional hazard models identified risk factors (e.g., demographics, clinical features, etiologic agents) associated with critical care or death. Findings: Of 1,090 CAP patients, the median age was 69 years; 38.4% were female. Influenza viruses were detected in 12.3%, RSV in 2.2%, and ORV in 6.3% of participants. Critical care was required for 39.4%, with 9.9% in-hospital mortality and 5% 30-day post-discharge mortality. Only 41% of influenza CAP patients received antiviral treatment. Admission factors independently associated with ICU admission included respiratory rate >30/min, blood urea nitrogen>19mg/dl, altered sensorium, anemia, oxygen saturation <90%, prior cardiovascular diseases, chronic respiratory diseases, and private hospital admission. Diabetes, anemia, low oxygen saturation at admission, ICU admission, and mechanical ventilation were associated with 30-day mortality. Conclusion: High ICU admission and 30-day mortality rates were observed among older adults with pneumonia, with a significant proportion linked to influenza and RSV infections. Comprehensive guidelines for CAP prevention and management in older adults are needed, especially with the co-circulation of SARS-CoV-2.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2024 (prima pubblicazione 2024-05-02).
Identificativi: PMID 38696397 · PMCID PMC11065220 · DOI 10.1371/journal.pone.0297452.
Descrittori MeSH principali: Pneumonia; Hospitalization.
Pagina: https://europepmc.org/article/MED/38696397 — https://doi.org/10.1371/journal.pone.0297452. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T17:12:53.207Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.